. AP remains in amyloid deposits for prolonged periods without protein catabolism (6) and might thereby contribute to the persistence which underlies their pathogenicity. However, the structure ofAP has not been well characterized. AP from only one individual has been completely sequenced at the protein level (7), and the two reports of the SAP cDNA sequence (8, 9), as well as preliminary reports of the glycostructure (10, 11, 37) , are conflicting. We have therefore compared the complete covalent structures of SAP and AP, with particular emphasis on the oligosaccharide and its role in turnover of the SAP glycoprotein.
glycoproteins. The protein and the glycan stctues of AP were also invariant, their rance to degradation s I a role in persistence of amyloid dests. Aslalo-SAP was rapidly cleared from the circulation in mice by a me m dependent on terminal g ee residues and was cataboie in hepatocytes. However blockade of this pathway did not affect the clarance of native SAP. Rapid hepatic uptake and catabolism of human asialo-SAP in man were also direcy demonstrated. The protein and glycan homogeneity of SAP and the integrity of APsuggest that the complete glycoprotein tructure is important for the normal and the pathophysologcal hfnctions of this molecule.
Human serum amyloid P component (SAP) is a normal plasma protein (1) and the precursor ofamyloid P component (AP) (2) , a universal constituent of the abnormal tissue deposits in amyloidosis (3), including Alzheimer disease (4, 5) . AP remains in amyloid deposits for prolonged periods without protein catabolism (6) and might thereby contribute to the persistence which underlies their pathogenicity. However, the structure ofAP has not been well characterized. AP from only one individual has been completely sequenced at the protein level (7) , and the two reports of the SAP cDNA sequence (8, 9) , as well as preliminary reports of the glycostructure (10, 11, 37) , are conflicting. We have therefore compared the complete covalent structures of SAP and AP, with particular emphasis on the oligosaccharide and its role in turnover of the SAP glycoprotein.
MATERIALS AND METHODS Proteins. SAP was isolated from the serum (13) of two healthy subjects, from two large pools of normal serum containing 1-ml aliquots from each of >5000 different healthy volunteer blood donors, and from a pool of malignant effusion fluids containing material from >300 donors. AP was isolated from two spleens containing AA amyloid, two spleens and two livers with AL amyloid, one spleen containing [ArgW]apolipoprotein A-I amyloid, and the spleen, liver, heart, kidney, and adrenals of an individual patient with AA amyloidosis. Amyloidotic tissue was homogenized in 0.01 M Tris/0.14 M NaCl/0.01 M EDTA, pH 8.0, and the supernatant after centrifugation at 50,000 x g for 30 min was dialyzed extensively into 0.01 M Tris/0.14 M NaCl/0.002 M CaCl2, pH 8.0, before extraction of AP precisely as described for SAP from serum (13) . All SAP/AP preparations were >991% pure in heavily overloaded SDS/polyacrylamide gradient gels (Excelgel, Pharmacia) run under reducing conditions and stained with brilliant blue R-350 or with silver.
Glycan Structure Analysis. Oligosaccharides attached to SAP and AP were released by hydrazinolysis and radiolabeled with sodium borotritide at the reducing terminus, which incorporates a single label into each chain independently of its structure, so that the relative molar proportions of all glycans present can be estimated directly (14) . These oligosaccharides were analyzed by high-voltage paper electrophoresis in pyridine/acetic acid water (3:1:387 by volume) at pH 5.4, 80 V/cm. They were then converted to neutral glycans by neuraminidase digestion and were analyzed on a highresolution 1.5 cm x 2 m Bio-Gel P-4 (<400 mesh) column by elution at 550C with water (14) . The structure was determined by sequential exoglycosidase digestion in combination with permethylation and GS-MS (14) . Heterogeneity of sialic acid linkage in the A-1 and A-2 structures was determined by digestion with neuraninidase from Newcastle disease virus, specific for a2-3 bonds, and neuraminidase from Arthrobacter ureafaciens, which cleaves a2-3(6) bonds, followed by selective exoglycosidase digestion and product analysis using permethylation and GC-MS (14 (Oxford GlycoSystems, Abingdon, Oxon, U.K.). Complete removal of sialic acid was confirmed by electrophoresis and by ES-MS analysis (see Fig. 2 12 hr with 140 ,uM cytidine 5 '-monophospho-N-acetylneuraminic acid (Sigma), bovine serum albumin (830 pg/ml), and rat liver sialyltransferase (33 milliunits/ml) (Sigma) in 50 mM sodium cacodylate/0.5% (vol/vol) Triton CF-54 at pH 6.0. Acquisition of sialic residues was confirmed by complete restoration of the normal anodal electrophoretic mobility of the SAP.
Turnover Studies in Mice. SAP was oxidatively iodinated with 1251 (2) (3) (4) (5) MBq/mg) by using N-bromosuccinimide (17) . Female CBA/Ca mice (Bantin & Kingman, Hull, U.K.), [6] [7] [8] [9] [10] [11] [12] weeks old, each received 2-10 pg of 1251-SAP in 200 A4
intravenously. In experiments with AGP and asialo-AGP, this was administered simultaneously. Precisely measured tail bleeds (0.01-0.04 g) were taken at the time intervals shown and trichloroacetic acid-precipitable radioactivity was counted in the same run at the end of each experiment together with standard aliquots of the injected tracer.
Trapped Catabolism Studies. 1251-tyramine cellobiose (125I-TCB) was synthesized and conjugated to SAP as described (18) . Both intact SAP and asialo-SAP labeled by covalent attachment of 1251-TCB retained in full their in vitro ligandbinding capacity (13) , and the plasma clearance of 125I-TCBlabeled intact SAP was identical with that of directly iodinated intact SAP. Since 125I-TCB labeling did not alter the properties or behavior of the protein, the site of catabolism of the 125I-TCB-SAP complex therefore indicates the site of catabolism of native SAP. After intravenous injection of 125I-TCB-labeled protein and the usual plasma clearance study, mice were killed at 24 hr, the organs were removed for measurement of radioactivity individually, and histological autoradiographs of the livers were prepared (19 points the SD was <10o of the mean); o, o, and *, X symbol corresponds to one of the same three volt previously received normal SAP). The plasma ha SAP was 24 hr, as previously reported (6), con extremely rapid clearance of asialo-SAP in the sai Anterior scintigraphic images of the torso taken at after intravenous injection of 123I-asialo-SAP into a h Initially (frame 1) there was activity only in the bloo liver rapidly became as radioactive as the heart (frar then (from frame 4 onward) radioactivity in the progressively as all the tracer was cleared from (Inset) Graph shows acquisition of radioactivity (ki] ond, keps) in the liver as a function of time (kilc nor in SAP or AP from individuals have we observed a species of 25,469 Da, the mass expected if there was proline A SAP (7, 8) rather than serine (9) at residue 82. More importantly there was no difference between AP and normal SAP, nor any evidence of postsecretory modification of AP. Effect of Oflgosaccbaride Modification on SAP Turnover in Mice. Desialylated human 1251-SAP, labeled directly by oxidative iodination, was extremely rapidly cleared from the circulation in mice (Fig. 3A) and completely catabolized with prompt urinary excretion of all radioactivity in trichloroacetic acid-soluble form. When SAP was labeled with 125I-TCB, S80 1000 a nondegradable tracer which is retained in the lysosomes of the cells in which the protein is catabolized (18), both fully sialylated and asialo forms of human SAP were taken up significantly only in the liver (Fig. 3B) . Retained activity at 24 hr, detected by autoradiography, was confined to hepatocytes. In contrast, virtually all the activity from directly iodinated SAP was excreted after prompt catabolism of the protein, and there was no significant retention in the tissues (Fig. 3B) . Degalactosylated asialo-SAP was cleared at a rate intermediate between that of normal and desialylated SAP (Fig. 3C ) and was also taken up in the liver, although the cellular location was not determined. Simultaneous administration of asialo-AGP temporarily normalized clearance of asialo-SAP, in a dose-dependent manner (Fig. 3A) . Enzymatic resialylation of asialo-SAP also restored its clearance to normal (Fig. 3D) . Desialylated human SAP is thus apparently cleared by binding to the hepatocyte asialoglycoprotein receptor (22) . However, this is evidently not the normal catabolic pathway for intact native human SAP, since the plasma half-like was unaffected by complete receptor blockade (Fig. 3A) . The usual route may thus involve protein rather than carbohydrate recognition. Clearance of Asialo-SAP in Man. Asialo-SAP was cleared extremely rapidly from the circulation by the liver in normal healthy men (Fig. 4A) . Scintigraphic imaging after injection of 123I-asialo-SAP showed immediate blood pool distribution followed promptly by uptake in the liver. Activity there peaked after 40 min and then fell as radioactive breakdown products appeared in the urinary tract (Fig. 4B) . There was no uptake elsewhere in the body. In contrast, no local uptake is demonstrable after injection of normal SAP, and breakdown products appear in the urine much later (6, 20, 21) . DISCUSSION
The absence in the oligosaccharides of SAP or AP of the microheterogeneity characteristic of other glycoproteins is remarkable (23) , especially in the SAP isolated from malignant effusion fluids (Fig. 1B) and in AP from reactive (AA) amyloid. These molecules had been produced during sustained acutephase responses, conditions in which the quantity and complexity of glycosylation of other plasma glycoproteins of hepatic origin are most likely to be altered (24 locounts persec-)seconds, ksec).
(C) Posterior scintigraphic image of the torso of the same individual taken at 4 hr. In addition to the strong liver signal, tracer was present in the kidneys, ureters, and bladder, demonstrating the pathway of excretion of iodinated breakdown products of the labeled SAP.
terminal sialic residues led to immediate clearance and catabolism via the hepatocyte asialoglycoprotein receptor. We also observed similarly accelerated hepatic uptake and breakdown of human asialo-SAP in man. Although specific hepatic localization of 99mTc-labeled galactosyl neoglycoalbumin (28) and asialo-orosomucoid (29) has been reported previously, we have directly demonstrated the carbohydrate-dependent catabolism of an autologous plasma glycoprotein in man.
Apart from rat C-reactive protein (CRP) (30), the main oligosaccharide of which is closely similar or identical to that described here for human SAP (31), such high-efficiency uptake by the asialoglycoprotein receptor has not been observed before, either in vivo or in vitro, with biantennary oligosaccharides, as, for example, on transferrin (22) . This uptake probably reflects the multimeric assembly of the protomers of SAP and of rat CRP (32), both of which belong to the pentraxin family of plasma proteins, since binding and uptake via this receptor are directly related to the degree of branching of oligosaccharides with terminal galactose or N-acetylgalactosamine residues (22) .
However, the clearance of normally sialylated SAP was unaffected by total blockade of the asialoglycoprotein receptor, indicating that normal SAP turnover may involve a protein rather than a carbohydrate-recognition step. Indeed, human CRP, which is not glycosylated, is cleared even more rapidly than intact sialylated SAP, both in man (33) and in mouse (34) , in which it is also exclusively catabolized by hepatocytes (unpublished observations). The existence of such an efficient clearance mechanism for asialo-SAP suggests that integrity of the oligosaccharide may be important or that altered SAP may be harmful.
Our results are thus of interest with regard both to the metabolism of plasma glycoproteins in general and to the role ofSAP in particular. It is not clear whether presence in plasma of the single invariant glycoform of SAP reflects a unique biosynthetic pathway (for which, incidentally, there is little precedent) or results from a postsecretory skimming process. If SAP molecules alternatively glycosylated during biosynthesis were preferentially cleared, like the asialo-SAP generated in vitro, or were more susceptible to proteolysis, then only the intact proteinase-resistant glycoform would be demonstrable.
Asn32, the N-glycosylation site of SAP (7), is on a (-strand lying under the single a-helix on the face of the protomer opposite to the calcium and ligand binding site (35) . The protomers are arranged as two pentameric discs interacting face-to-face, and since the native decamer displays maximal calcium-dependent ligand binding (1), the glycans must be attached to the promoter faces involved in the pentamerpentamer interaction. However, the dimensions of the oligosaccharide are 55 A x 0.5 A x 24 A (36) and it must therefore extend outward from each 20-A protomer. Desialylated SAP retained fully the capacity to bind in vitro to amyloid fibrils (13) and to DNA (12) , and it also remained decameric (data not shown). Nevertheless, the presence ofglycan on the promoter surfaces involved in pentamerf-pentamer association may contribute to decamer assembly during biosynthesis. Studies of this question and of the effects of the oligosaccharide on stability and proteinase resistance of SAP could have implications for the clinical use of modified glycoforms of SAP in diagnosis and therapy of amyloidosis (20 
